These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17340060)

  • 1. [Asymmetric dimethyl arginine (ADMA): a novel cardiovascular risk factor?].
    Stühlinger M
    Wien Med Wochenschr; 2007 Feb; 157(3-4):57-60. PubMed ID: 17340060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetric dimethyl L-arginine (ADMA) is a critical regulator of myocardial reperfusion injury.
    Stühlinger MC; Conci E; Haubner BJ; Stocker EM; Schwaighofer J; Cooke JP; Tsao PS; Pachinger O; Metzler B
    Cardiovasc Res; 2007 Jul; 75(2):417-25. PubMed ID: 17559823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance.
    Toutouzas K; Riga M; Stefanadi E; Stefanadis C
    Horm Metab Res; 2008 Sep; 40(9):655-9. PubMed ID: 18792879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease.
    Selley ML
    Neurobiol Aging; 2003 Nov; 24(7):903-7. PubMed ID: 12928048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
    Sydow K; Hornig B; Arakawa N; Bode-Böger SM; Tsikas D; Münzel T; Böger RH
    Vasc Med; 2004 May; 9(2):93-101. PubMed ID: 15521698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine.
    Thum T; Tsikas D; Stein S; Schultheiss M; Eigenthaler M; Anker SD; Poole-Wilson PA; Ertl G; Bauersachs J
    J Am Coll Cardiol; 2005 Nov; 46(9):1693-701. PubMed ID: 16256870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADMA and hyperhomocysteinemia.
    Dayal S; Lentz SR
    Vasc Med; 2005 Jul; 10 Suppl 1():S27-33. PubMed ID: 16444866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.
    Stühlinger MC; Stanger O
    Curr Drug Metab; 2005 Feb; 6(1):3-14. PubMed ID: 15720202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma asymmetric and symmetric dimethylarginine in a rat model of endothelial dysfunction induced by acute hyperhomocysteinemia.
    Magné J; Huneau JF; Borderie D; Mathé V; Bos C; Mariotti F
    Amino Acids; 2015 Sep; 47(9):1975-82. PubMed ID: 25792109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelium is the organ chiefly responsible for the catabolism of plasma asymmetric dimethylarginine--an explanation for the elevation of plasma ADMA in disorders characterized by endothelial dysfunction.
    McCarty MF
    Med Hypotheses; 2004; 63(4):699-708. PubMed ID: 15325021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA.
    Sydow K; Mondon CE; Cooke JP
    Vasc Med; 2005 Jul; 10 Suppl 1():S35-43. PubMed ID: 16444867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations of asymmetric dimethylarginine, nitric oxide and homocysteine in patients with slow coronary flow.
    Yucel H; Ozaydin M; Dogan A; Erdogan D; Turker Y; Ceyhan BM; Sutcu R
    Scand J Clin Lab Invest; 2012 Oct; 72(6):495-500. PubMed ID: 22950626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
    Yamagishi S; Ueda S; Okuda S
    Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of asymmetric dimethylarginine and endothelial dysfunction.
    Böger RH
    Clin Chem Lab Med; 2003 Nov; 41(11):1467-72. PubMed ID: 14656027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis.
    Elesber AA; Solomon H; Lennon RJ; Mathew V; Prasad A; Pumper G; Nelson RE; McConnell JP; Lerman LO; Lerman A
    Eur Heart J; 2006 Apr; 27(7):824-31. PubMed ID: 16434411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis.
    Weis M; Kledal TN; Lin KY; Panchal SN; Gao SZ; Valantine HA; Mocarski ES; Cooke JP
    Circulation; 2004 Feb; 109(4):500-5. PubMed ID: 14732750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay.
    Schulze F; Wesemann R; Schwedhelm E; Sydow K; Albsmeier J; Cooke JP; Böger RH
    Clin Chem Lab Med; 2004; 42(12):1377-83. PubMed ID: 15576299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetric dimethylarginine plasma levels and endothelial function in newly diagnosed type 2 diabetic patients.
    Sciacqua A; Grillo N; Quero M; Sesti G; Perticone F
    Int J Mol Sci; 2012 Oct; 13(11):13804-15. PubMed ID: 23203035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of homocysteine, asymmetric dimethylarginine and nitric oxide in pre-eclampsia.
    Demir B; Demir S; Pasa S; Guven S; Atamer Y; Atamer A; Kocyigit Y
    J Obstet Gynaecol; 2012 Aug; 32(6):525-8. PubMed ID: 22779953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum homocysteine, asymmetric dimethyl arginine (ADMA) and other arginine-NO pathway metabolite levels in patients with psoriasis.
    Bilgiç Ö; Altınyazar HC; Baran H; Ünlü A
    Arch Dermatol Res; 2015 Jul; 307(5):439-44. PubMed ID: 25708188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.